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A common finding when measuring T cell immunity to enteric bacterial vaccines in humans
is the presence of background responses among individuals before immunization. Yet the
nature of these background responses remains largely unknown. Recent findings show
the presence in uninfected individuals of mucosal associated invariant T (MAIT) cells that
mount broad spectrum immune responses against a variety of microorganisms including
Mycobacterium tuberculosis and enteric bacteria such as Escherichia coli and Salmonella.
Therefore, we investigated whether MAIT immune responses to intestinal bacteria might
account for the background responses observed before immunization. Here we measured
MAIT immune responses to commensal and enteric pathogenic bacteria in healthy individ-
uals with no history of oral immunization with enteric bacteria. We found that MAIT cells
were activated by B cells infected with various bacteria strains (commensals and pathogens
from the Enterobacteriaceae family), but not by uninfected cells. These responses were
restricted by the non-classical MHC-related molecule 1 (MR1) and involved the endocytic
pathway.The quality of these responses (i.e., cytokine profile) was dependent on bacterial
load but not on the level expression of MR1 or bacterial antigen on B cell surface, suggest-
ing that a threshold level of MR1 expression is required to trigger MAIT activation. These
results provide important insights into the role of B cells as a source of antigen-presenting
cells to MAIT cells and the gut immune surveillance of commensal microbiota.
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INTRODUCTION
A common finding when measuring T cell immune responses
in humans to enteric bacterial vaccines is the presence of back-
ground responses among individuals before immunization (1–5).
Although this background is rather variable, with higher levels
observed in individuals in regions of the world with limited san-
itation systems, it has been observed in subjects across the World
(unpublished data). Yet the nature of these background responses
remains largely unknown. Interestingly, it has been recently shown
that uninfected individuals can harbor strong immune responses
to the Mycobacterium tuberculosis (Mtb) bacterium and enteric
bacteria such as Escherichia coli (E. coli) and Salmonella enterica
serovar Typhimurium (S. Typhimurium) (6, 7). These responses
are mediated by mucosal associated invariant T (MAIT) cells, a
population of T cells that display a TCR Vα7.2+CD161+ pheno-
type and which are restricted by the non-classical MHC-related
molecule 1 (MR1) (7). After birth, MAIT cells acquire a memory
phenotype and expand dramatically, up to 1–4% of human blood
T cells (8). Moreover, it has been shown that MAIT cells are abun-
dant in the human intestine, and experiments in mice indicated
that their accumulation in the periphery requires B cells and com-
mensal flora (7, 9). Indeed MAIT cells are absent from germ-free
mice but can be developed after bacterial colonization (7).
Therefore, it is reasonable to speculate that MAIT cell immune
responses to intestinal bacteria might be the source, at least in
part, of the background responses observed before immunization.
To evaluate this hypothesis we measured MAIT cell immune
responses to intestinal microbes, including commensals (i.e., E.
coli HS and Nissle 1917 strains) and enteric pathogenic bacte-
ria [S. enterica serovar Typhi (S. typhi), Enteropathogenic E. coli
(EPEC) and Entero-Invasive E. coli (EIEC)] in healthy individu-
als without a history of enteric bacterial immunization. We found
that B cells might be a source of antigen-presenting cells (APCs)
to MAIT cells. Indeed, MAIT cells were activated by all bacteria-
infected B cells (used as APC in these studies) tested, but not
by uninfected cells. These responses were restricted by the non-
classical MR1 restricted and involved the endocytic pathway. The
quality of these responses (i.e., cytokine profile) was dependent on
bacterial load but not on the level expression of MR1 or bacterial
antigen on B cell surface, suggesting that a threshold level of MR1
expression is required to trigger MAIT activation. These results
provide important insights into the role of B cells as a source of
APC to MAIT cells and the gut immune surveillance of commensal
microbiota.
MATERIALS AND METHODS
BACTERIAL STRAINS
Three commensals E. coli strains were used, i.e., BL21 [obtained
from Dr. Tettelin’s laboratory (laboratory strain derived from
a normal commensal of the human gut, isolated from human
feces)] (10), HS [obtained from the Center for Vaccine Develop-
ment (CVD) collection of commensal E. coli (clinical isolate)]
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(11), and E. coli Nissle 1917 [kindly provided by Sonnenborn,
Ardeypharm, Germany (a probiotic E. coli strain)] (12, 13). Three
enteropathogens were also used: two E. coli strains, i.e., EPEC
strain O127H6 [obtained from the CVD collection (reference
strain)] and EIEC strain CDC EDL (ATCC, Rockville, MD, USA)
and wild type S. enterica serovar Typhi (S. typhi) strain ISP1820
(obtained from the CVD collection) (1, 2, 5, 14–17). Listeria mono-
cytogenes (obtained from the CVD collection) was used as negative
control.
BACTERIA MEDIA AND GROWTH CONDITIONS
Luria–Bertani (LB) agar broth Lennox (Difco Laboratories,
Detroit, MI, USA) and LB agar Lennox (Difco) were prepared
according to the package instructions. For infection experiments
with E. coli strains, bacteria were grown overnight in LB broth
with vigorous shaking (~300 rpm) at 37°C. The following morn-
ing, the starter culture was diluted 1/50–1/100 into LB medium,
and grown for 2.5–3.0 h. To ensure that the culture did not grow
to a high density, measurements the OD600 of the culture were
performed every 15–20 min. The cultures were stopped when they
approached 0.4, which for most strains of E. coli is equivalent to
108 bacteria/ml. The cultures were then pelleted, resuspended in
RPMI media (without antibiotics) and used to infect cells. For
infection experiments with S. typhi, cells were grown as above
described and the cultures were stopped when they approached
0.2 which for S. typhi is equivalent to 108 bacteria/ml.
Listeria monocytogenes were cultured on blood agar plates
(5% bovine blood in blood agar base) at 37°C as previously
described (18).
SUBJECTS
Seven healthy volunteers, between 24 and 41 years old, recruited
from the Baltimore-Washington area participated in this study.
Volunteers were screened for previous vaccination history, good
health by medical history, physical examination, and normal labo-
ratory tests, including blood counts, and the absence of antibiotic
treatment. Volunteers were explained the purpose of this study
and gave informed, signed consent. Peripheral blood mononuclear
cells (PBMC) were isolated by density gradient centrifugation and
cryopreserved in liquid N2. These PBMC were used ex vivo as
effectors cells. The human experimentation guidelines of the US
Department of Health and Human Services and those of the Uni-
versity of Maryland, Baltimore, were followed in the conduct of the
present clinical research. All blood specimens were collected from
volunteers that participated in the University of Maryland Insti-
tutional Review Board approved protocol number HP-00040025
that authorized the collection of blood specimens for the studies
included in this manuscript.
ANTIBODIES, CELL CULTURE MEDIA, AND REAGENTS
Cells were stained with monoclonal antibodies (mAbs) to CD3
(clone UCHT1), CD69 (clone TPI-55-3) (Beckman-Coulter,
Miami, FL, USA), CD8 (clone HIT8a), CD161 (clone DX12), inter-
feron (IFN)-γ (clone B27), tumor necrosis factor (TNF)-α (clone
MAb11) (BD Pharmingen, San Diego, CA, USA), CD14 (clone
TuK4), CD19 (clone SJ25-C1), CD45 (clone H130) (Invitrogen,
Carlsbad, CA, USA), interleukin (IL)-17A (clone eBio64DEC17)
(eBioscience, San Diego, CA, USA), TCRα7.2 (clone 3C10) (Biole-
gend, San Diego, CA, USA). These antibodies were directly conju-
gated to the following fluorochromes: fluorescein isothiocyanate
(FITC), Phycoerythrin (PE), PE-Cy7, Energy Coupled Dye or PE-
Texas-Red conjugate (ECD), Pacific Blue, Pacific Orange, Alexa
647, allophycocyanin (APC)-Alexa 700, and APC-Cy7.
Anti-MR1 (clone 26.5) (kindly provided by Dr. Ted H. Hansen)
as well as anti-MR1 (goat polyclonal) (Santa Cruz Biotechnology,
San Diego, CA, USA) and anti-MR1 (rabbit polyclonal) (GeneTex,
Irvine, CA, USA) antibodies were used in this manuscript. Unless
stated otherwise, surface staining for MR1 proteins were done
mainly using anti-MR1 polyclonal antibodies. Of note, all three
anti-MR1 antibodies were able to detect MR1-expressing cells at
similar levels (Figure S1 in Supplementary Material). However, in
our hands MR1 clone 26.5 possessed the best blocking proper-
ties and it was chosen as the election antibody for the blocking
experiments. Secondary antibodies included FITC-donkey anti-
goat IgG (Santa Cruz) and -PE F(ab′)2-Donkey anti-Rabbit IgG
(BD Pharmingen). Both secondary antibodies were pre-adsorbed
by the manufacturers. Of note, anti-MR1 (GeneTex) antibodies
directly conjugated by our group to APC were also used in these
studies.
Culture medium consisted of RPMI 1640 (Gibco, Grand Island,
NY, USA) supplemented with 100 U/ml penicillin, 100µg/ml
streptomycin, 50µg/ml gentamicin, 2 mM l-glutamine, 2.5 mM
sodium pyruvate, 10 mM HEPES buffer, and 10% heat-inactivated
fetal bovine serum (R10).
Purified Lipid A (LPA) (the biologically active component of
lipopolysaccharide) from E. coli F583 Rd mutant, lactacystin (LC),
and cytochalasin D (CCD) were purchased from Sigma) (St. Louis,
MO, USA).
TARGET CELLS
Autologous Epstein–Barr virus (EBV)-transformed lymphoblas-
toid B cell lines (B-LCL), primary B cells, and an epithelial cell
line were used as targets. B-LCLs were established from PBMC,
described in the above Section “Subjects,” following standard pro-
cedures using B95-8 cell line (ATCC) supernatants as the source
of EBV (19, 20). After transformation, B-LCL were maintained
in culture in R10 medium or cryopreserved until used in the
experiments.
Primary B cells were isolated from PBMC by negative selection
using untouched human B cell immunomagnetic bead kit (Invit-
rogen). Isolation was performed as per manufacturer’s instruc-
tions. B cell populations were >85% pure as determined by flow
cytometric analysis. B cells were used immediately after isolation.
The epithelial cell line used was the human enterocyte cell
line (HCT-8) that was originally derived from the junction of the
small and large bowels (21). HCT-8 cells were cultured as previous
described (17) in R10 medium.
INFECTION OF TARGET/STIMULATOR CELLS
Cells were infected as previously described (1, 2, 5, 14–16) with
slight modifications. Briefly, target cells were infected by incuba-
tion in RPMI (without antibiotics) at 37°C for 2 or 3 h with any
of the E. coli strains or S. typhi, respectively at different multi-
plicity of infection (MOI). After incubation, cells were washed
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and incubated for an additional 16–18 h in complete R10 contain-
ing gentamicin (100µg/ml) to kill extracellular and/or to detach
cell-bound bacteria. The presence of E. coli surface antigens was
measured by flow cytometry. To confirm that targets were infected
with E. coli, cells were stained with protein-A purified anti-E. coli-
FITC IgG (AbCam). To confirm that targets were infected with
S. typhi, cells were stained with anti-CSA-1-FITC (KPL, Gaithers-
burg, MD, USA). In some experiments, targets were pretreated
with inhibitors before infection. For pretreatments, cells were
incubated with the indicated concentrations of LC and CCD 2 h
before infection. Unless stated otherwise, targets were infected at
1:30 MOI.
For co-culture of target and MAIT cells, after treatment with
gentamicin targets were irradiated (6,000 rads) and surface stained
with anti-CD45, a marker abundantly expressed on the surface of
hematopoietic cells (22). This enabled the electronic gating of the
target cells during flow cytometric analysis.
BACTERIA ENTRY ASSAYS
Bacteria entry experiments were performed as previously
described (23–25). Briefly, after gentamicin treatment targets were
lysed with 1% Triton X-100 in PBS, diluted to 1 ml with LB broth,
and 100µl aliquots were plated on LB agar. Colonies were counted
after an overnight incubation.
SURFACE AND INTRACELLULAR STAINING
CD45-stained-target cells were co-cultured with overnight-rested
ex vivo PBMC at a PBMC to target cell ratio of 5:1. PBMC cultured
with uninfected target cells or Staphylococcus enterotoxin B (SEB)
(10µg/ml, Sigma, St. Louis, MO, USA) were used as negative and
positive controls, respectively. After 1–2 h of stimulation, protein
transport blockers, Monensin (1µg/ml, Sigma) and brefeldin-
A (BFA) (2µg/ml, Sigma), were added to the co-culture. After
overnight (16–18 h) incubation, cells were harvested, stained with
a dead-cell discriminator, violet fluorescent viability dye (ViViD,
Invitrogen) (26), followed by surface staining with mAbs against
surface antigens (CD3, CD8, CD14, CD19, TCRα 7.2, and CD161)
and fixation and permeabilization with Fix and Perm cell buffers
(Invitrogen, Carlsbad, CA, USA). Cells were then stained intracel-
lularly for IFN-γ, TNF-α, IL-17A, and CD69. Finally, cells were
fixed and analyzed by flow cytometry on an LSR-II instrument
(BD Biosciences). Data were analyzed with WinList v7.0 (Verity
Software House, Topsham, ME, USA). Lymphocytes were gated
based on their scatter characteristics. Single lymphocytes were
gated based on forward scatter height vs. forward scatter area. A
“dump” channel was used to eliminate dead cells (Violet Viability
Dye;ViViD+) as well as macrophages/monocytes (CD14+),B lym-
phocytes (CD19+), and targets (CD45+) from analysis. This was
followed by additional gating on CD3, CD8, TCR Vα7.2, CD161 to
identify cytokine-producing (IFN-γ, TNF-α, and IL-17A) MAIT
cells.
Statistical analysis
All statistical tests were performed using Prism software (ver-
sion 5.02, GraphPad software, La Jolla, CA, USA). Comparisons
between groups were performed using Pearson Product Moment
Correlation tests. p Values <0.05 were considered significant.
RESULTS
EXPRESSION OF E. COLI ANTIGENS ON TARGET CELLS
To investigate the role of MAIT cells in detecting and respond-
ing to commensal bacteria, we decided to modify an experimental
protocol previously described for S. typhi infection (1, 5, 14, 16,
17) to enable cellular infection and antigen presentation of com-
mensal bacteria antigens. We used E. coli and lymphoblastoid B
cell line (B-LCL) transformed by EBV as models of commensal
bacteria and APC, respectively. This strategy was based on three
main reasons. First, E. coli are normal residents of the gastroin-
testinal tract. They are traditionally extracellular organisms that in
certain conditions can result in opportunistic intracellular infec-
tions (27). Second, B cells are believed to be main contributors
as APC during the initial phases of host immune responses (28),
and are required for MAIT cell accumulation in the periphery (9).
Third, our group has a long track record of using B-LCL cells as
APC, in particular for bacterial antigen presentation (1, 2, 5, 16).
Indeed, these cells have demonstrated to be a very attractive model
because of their easiness to culture and their robustness to survive
after bacterial infection. Moreover, B cells are known to express the
CD161 MAIT cell ligand Lectin-like transcript-1 (LLT1) (29–31).
Herein, as a preliminary step, we evaluated whether the non-
pathogenic E. coli strains BL21, HS, and Nissle 1917 were able
to infect B-LCL targets and express antigens on their cell mem-
branes. To this end, B-LCLs were incubated with medium alone or
with any of the three E. coli strains for 2 h at different MOI. After
incubation, cells were washed and incubated for an additional 16–
18 h in complete RPMI containing gentamicin (100µg/ml) to kill
extracellular and/or to detach cell-bound bacteria. The presence
of E. coli surface antigens was measured by flow cytometry. We
observed that while all selected strains were able to express E. coli
antigens on the B-LCL cell membrane, they did it at different lev-
els. The percentage of cells expressing E. coli antigens was much
lower on B-LCLs exposed to HS and Nissle 1917 strains as com-
pared with those cells exposed to the BL21 strain (Figure 1A). In
contrast, no significant expression of E. coli antigens was observed
on the cell membrane of uninfected cells (Figure 1B). We also
observed that cells exposed to heat-killed E. coli had substantially
lower levels of E. coli antigens on the cell surface as compared
to cells exposed to live E. coli (Figure 1B). These results suggest
that expression of E. coli antigens on the cell membrane is largely
dependent on bacterial cell invasion.
To validate these findings, we next investigated the presence of
viable intracellular bacteria. In these experiments, E. coli strain
BL21, which induced high levels of expression of E. coli antigens
on the B-LCL cell membrane, was chosen as a model for bacterial
cell invasion. As described above, B-LCL were co-cultured with E.
coli for 2 h. After incubation, cells were treated with gentamicin for
an additional 2 or 16–18 h (overnight) to eliminate extracellular
bacteria. Cells were then extensively washed and lysed with 1%
Triton X-100. An aliquot of cell lysate was plated on LB agar and
BL21 colonies were counted after an overnight incubation. Media
with bacteria cultured alone (i.e., without B-LCL cells) were used
as control. As expected, cells exposed to heat-killed bacteria or
media only (no cells) demonstrated virtually no bacteria growth
on LB agar. In contrast, easily detectable colony-forming units
(CFU) were present in cells exposed to live bacteria (Figure 1C). To
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FIGURE 1 | Expression of E. coli antigens on B-LCL target cells. B-LCL
cells were infected with E. coli for 2 h followed by gentamicin treatment.
(A) B-LCL cells were infected with E. coli at different multiplicity of
infection (MOI, 1:3, 1:50, and 1:150) by either of the three strains: BL21,
HS, or Nissle 1917 for 2 h. The percentage of the E. coli -expressing cells
was assessed by flow cytometry after overnight treatment with
gentamicin. Bars represent mean±SE. (B) B-LCL cells were also exposed
to live or heat-killed E. coli strain BL21 and the percentage of E.
coli -expressing cells was evaluated by flow cytometry after overnight
treatment with gentamicin or (C) by counting the number of colony-forming
units (CFU) in cell lysates upon culture on agar plates. B-LCLs were
infected for 2 h followed by 2 h or overnight treatment with gentamicin.
Media (without B-LCL cells) was used as control for the presence of
extracellular bacteria. The CFU was normalized per milliliter. (D)To confirm
that anti-E. coli antibodies detect all E. coli strains being studied, these E.
coli strains as well as Listeria (negative control) were directly stained with
E. coli antibodies and analyzed by flow cytometry. (E) Infection was further
confirmed by electron microscopy. B-LCL cells were left untreated (none,
lower magnification) or exposed to live E. coli strain BL21 at a MOI of 1:100
[from left to right, lower (a), medium (b), or higher (c) magnification] and
treated with gentamicin for 2 h. After 2 h, B-LCL cells were washed and
cultured overnight in complete media with gentamicin (d) to control for
bacteria detachment. (F) In some experiments B-LCLs were pretreated
with lactacystin (LC) and cytochalasin D (CCD) for 2 h at different
concentrations before infection. Data are representative of five (A), three
(B), and two (C–F) experiments.
confirm that anti-E. coli antibodies bind to all E. coli strains being
studied, the three strains of E. coli, as well as a strain of Listeria
(negative control) were directly stained with E. coli antibodies and
analyzed by flow cytometry. We observed that while the median
fluorescence intensity (MFI) was different for each of the three E.
coli strains (Nissle 1917>HS>BL21), all of them were detected
by anti-E. coli antibodies (Figure 1D; Figure S2 in Supplementary
Material). These findings prompted us to examine the antibody
binding to E. coli by flow cytometry after adding different dilu-
tions of the purified polyclonal antibody preparation to the three
E. coli strains followed by the addition of anti-rabbit PE. As shown
in Figure S2 in Supplementary Material, the MFI revealed that
higher antibody concentrations were required to saturate Nissle
1917 and HS strains than BL21, suggesting that the latter have
less biding antigens available. The specificity of this polyclonal
antibody preparation was confirmed by the low/minimal binding
observed with L. monocytogenes (Figure 1D). Electron microscopy
examination of the infected B-LCL cells confirmed the presence
of intracellular E. coli BL21 strain. As shown in Figure 1E; 2 h
after infection, intracellular bacteria could be seen in the cyto-
plasm of B-LCL (Figure 1Ea, second panel from left to right).
We also observed bacteria in close proximity to the cells with the
cell membrane beginning to extend around individual bacteria
(Figure 1Eb, third panel from left to right). Finally, some bacteria
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were seen to induce pedestal-like formation, a critical step during
E. coli colonization (32) (Figure 1Ec, fourth panel from left to
right). As previously reported (5, 16, 33), no surface-bound bac-
teria were observed after an overnight treatment with gentamicin
(Figure 1Ed, last panel from left to right). Taken together, these
results demonstrated the ability of E. coli to efficiently infect a large
percentage of B-LCL. Based on these observations we hypothesized
that the presence of live bacteria inside of the cells might increase
the likelihood that E. coli proteins are being processed and gain
access to the host cell MHC class I antigen processing pathways
required for CD8+ T cell recognition. To test this assumption, we
examined the effect of LC, an inhibitor of proteasome process-
ing (14, 34), and the actin-depolymerizing agent CCD (35, 36),
an inhibitor of endocytosis, on E. coli antigen expression on B-
LCLs using flow cytometric assays. B-LCLs were pretreated with
LC or CCD for 2 h at different concentrations before infection.
Pretreatment of the cells with LC did not lead to a decrease in
the percentage of E. coli-expressing B-LCLs. Instead, we observed
an important decrease in the percentage of E. coli-expressing B-
LCLs in the presence of CCD (Figure 1F). Together, these data
suggested that E. coli antigen expression on targets is a result of
both endocytosis and bacterial invasion.
INFECTION-INDUCED MR1 EXPRESSION
Although, it has been demonstrated that human MAIT cells recog-
nized MR1 expressed on infected targets over-expressing human
MR1 (7), the MR1 surface expression of endogenous MR1 on tar-
get cells following bacterial infection has not yet been definitively
shown. To our knowledge, up-regulation of MR1 has been limited
to a modest increase in the A549 epithelial cell line (6). Thus, we
next investigated MR1 expression on the cell surface of B-LCL cells
in vitro infected with various bacteria. As described above, B-LCL
were cultured with medium only or with S. typhi or any of five E.
coli strains: commensals (i.e., E. coli strains BL21, Nissle 1917, or
HS) or pathogenic bacteria (i.e., EPEC and EIEC). B-LCLs were
then extensively washed and treated with gentamicin to eliminate
extracellular bacteria. After 16–18 h, B-LCL cells were stained with
MR1 antibodies and analyzed by flow cytometry. While B-LCL
cells infected with BL21 and EPEC induced high levels of MR1 on
the cell surface, B-LCL cells infected with E. coli strains HS and
Nissle 1917, EIEC, and S. typhi induced only low levels of MR1 on
the cell surface (Figures 2A,B). Because previous work has shown
the presence of MR1 proteins intracellularly in different types of
B and T cell lines (37), we speculated that MR1 proteins might
have been exported to the cell surface from a pool of endogenous
MR1 already present in the cytoplasm of target cells. Thus, B-LCL
targets were either surface stained only (non-permeabilized cells)
or surface and intracellular stained (total; permeabilized cells)
with anti-MR1 antibodies. Percentages of MR1 proteins expressed
on uninfected and BL21-infected B-LCL cells (MOI 1:30) were
determined by flow cytometry. While MR1 expression on the
surface of the target cell was restricted to targets infected with
BL21 strain, expression of total MR1 was found to be similar on
both uninfected and infected targets (Figure 2C). These results
support our hypothesis that bacterial infection might provide a
signal to endogenous MR1 proteins to be expressed at the cell
surface.
We next investigated whether the increase in MR1 expression
occurs in a more physiological situation. Because following inges-
tion E. coli and Salmonella are far more likely to first encounter
epithelial cells and then B cells, we evaluated surface MR1 expres-
sion on HCT-8 epithelial cells. These epithelial cells are human
enterocyte cell lines that were originally derived from the junction
of the small and large bowel (21). The choice of this cell line was
based on our previous work demonstrating its ability to secrete
cytokines (e.g., IL-1, IL-6, IL-8, IL-11, IL-12p70, IL-17A, IL-21,
and TNF-α following exposure to S. typhi (17). In agreement with
the above results using B-LCL cells, MR1 expression was increased
on HCT-8 cells after bacterial infection (Figure 2D). Like for B-
LCL cells the increases differed depending on the bacterial strain
tested. Interestingly, increases in MR1 expression were observed
on HCT-8 cells infected with both EPEC and E. coli strain HS
but not with S. typhi or EIEC (Figure 2D). To further confirm
our findings with B-LCL cells, we deemed of great importance to
investigate the effects of bacteria on MR1 expression on primary
human B cells. B cells purified from PBMCs were infected with
E. coli strain BL21 at different MOI and MR1 expression mea-
sured by flow cytometry. As for B-LCLs, a high proportion of E.
coli-infected primary B cells expressed MR1 proteins on their cell
membrane, compared to minimal MR1 expression in uninfected
cells (Figures 2E,F).
We next investigated whether there is a relationship between
MR1 up-regulation and infection levels. To this end, results on
the percentages of both MR1 and bacterial antigens expressed on
the surface of bacteria-infected B-LCL cells were divided into five
groups: (1) total, B-LCL cells infected with any bacteria tested
(commensals and pathogenic bacteria), (2) B-LCL cells infected
with commensals only (E. coli strains BL21, HS, and Nissle 1917),
(3) B-LCL cells infected with pathogenic bacteria only (S. typhi,
EPEC, and EIEC), (4) B-LCL cells infected with bacteria that
induce low levels of MR1 on the cell surface (E. coli strains HS
and Nissle 1917, EIEC and S. typhi), and (5) B-LCL cells infected
with bacteria that induce high levels of MR1 on the cell surface
(BL21 and EPEC). Comparisons among the different groups were
performed using Pearson Product Moment Correlation. We found
a striking correlation between MR1 up-regulation and infection in
the total group (p< 0.0001) (Figure 3A). These correlations were
driven by B-LCL cells infected with BL21 and EPEC (p< 0.0001)
(Figure 3A). No correlations were found in the group with B-
LCL cells infected with pathogenic bacteria only or in the group
with B-LCL cells infected with bacteria that induce low levels of
MR1 expression on the cell surface (p values= 0.438 and 0.751,
respectively) (data not shown). Finally, simultaneous flow cyto-
metric measurements of MR1 and E. coli antigens at the single cell
level showed that the vast majority of cells expressing MR1 were
also expressing E. coli antigens (Figure 3B; Figure S3C in Supple-
mentary Material). To further understand the mechanism of MR1
up-regulation after bacterial infection, we examined the effect of
LC and CCD on MR1 expression on E. coli-infected B-LCLs using
flow cytometric assays. B-LCLs were pretreated with LC or CCD
for 2 h at different concentrations before infection. Similar to E.
coli antigen expression, pretreatment of the cells with LC did not
lead to a decrease in the percentage of MR1-expressing B-LCLs.
Instead, we observed an important decrease in the percentage of
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FIGURE 2 | MHC-related molecule 1 proteins are exported to the surface
of bacteria-infected-cells. B-LCL cells were infected with either commensals
(A) (i.e., E. coli strains BL21, Nissle 1917, or HS) or pathogenic bacteria
(B) (i.e., EPEC or EIEC or S. typhi ) for 2 h at different multiplicity of infection
(MOI) (1:1, 1:10, and 1:100 for commensals and 1:0.3, 1:3, and 1:30 for
pathogenic strains). Cells left uninfected were used as controls. After 16–18 h
of gentamicin treatment cells were stained with MR1 antibodies and analyzed
by flow cytometry. (C) Permeabilized (total) and non-permeabilized (surface)
B-LCL targets were stained with anti-MR1 antibodies. Percentages of MR
proteins on uninfected (solid histogram and dashed line) and
BL21-infected-cells (MOI 1:30) (full and dotted lines) were determined by flow
cytometry. (D) HCT-8 epithelial cells were left uninfected or infected with
either S. typhi, EIEC, EPEC, or E. coli HS at an MOI of 1:100 for 2 h. After
16–18 h of gentamicin treatment cells were stained with MR1 antibodies and
analyzed by flow cytometry. Numbers correspond to the % of MR1 positive
cells followed by mean fluorescence intensity (MFI) of positive cells (in
parenthesis). Primary B cells were also infected with E. coli strain BL21 at
different MOI (· · · , 1:3; · · · ,1:10; and · · · , 1:30) and surface expression of E.
coli antigens (E) and MR1 expression (F) measured by flow cytometry. Data
are representative of five (A,B) and two (B–F) experiments.
MR1-expressing B-LCLs in presence of CCD (Figure 3C; Figure
S3C in Supplementary Material). Because it remained possible that
recognition of bacteria by B cells was sufficient to up-regulate MR1
without bacterial endocytosis, we examined MR1 up-regulation in
B-LCL stimulated with Lipid A (LPA), the hydrophobic anchor
of lipopolysaccharide (LPS). LPA is known to signal indepen-
dently of phagocytosis, and therefore independently of CCD. It
is also known that the actin cytoskeleton is not only important for
phagocytosis but also for cell signaling through several receptors.
Specifically, recent studies have shown that under altered physio-
logical conditions LPS might be able to stimulate human B cells
(38, 39). Thus, to evaluate this possibility, B-LCL cells were cul-
tured in medium alone or with purified LPA (1, 3, and 10µg/ml)
and MR1 up-regulation evaluated by flow cytometry. No MR1
up-regulation was observed at any of the LPA concentrations eval-
uated (Figure S3A in Supplementary Material). To control for
autofluorescence and background non-specific staining resulting
from the rabbit polyclonal anti-MR1 antibodies, we stained unin-
fected and E. coli-infected B-LCL cells with normal rabbit sera
(non-immune rabbit). As shown in Figure S3C in Supplementary
Material, we observed little or no staining in the cells treated with
normal rabbit sera, indicating that polyclonal rabbit anti-MR1
antibodies were specifically associated with MR1 antigen. More-
over, to exclude the possibility that our observations were due to
cross-reactivity between antibodies to MR1 and E. coli antigens
we stained E. coli strain BL21 bacteria with the polyclonal rabbit
anti-MR1 antibodies. As shown in Figure S3D in Supplementary
Material, only marginal cross-reactivity was observed.
These results suggest that bacterial-induced MR1 expression
relies on an endocytic event rather than on direct bacterial con-
tact to the cell surface or on a proteasome-dependent pathway.
These results are in agreement with previous work using an MR1
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FIGURE 3 | Correlation between MR1 up-regulation and levels of
bacterial infection. (A) Percentage of both MR1 and bacterial antigens
on the surface of B-LCL cells were measured by flow cytometry.
Results were divided into three groups: (1) total, B-LCL cells infected
with any bacteria tested (commensals and pathogenic bacteria), (2)
B-LCL cells infected with commensals only, and (3) B-LCL cells infected
with bacteria that induce high levels of MR1 on the cell surface (BL21
and EPEC ). Correlation coefficients “r” and “p” values are shown. p
Values of <0.05 were considered statistically significant. Comparisons
between groups were performed using Pearson Product Moment
Correlation tests. (B) A representative flow cytometric experiment
using polyclonal antibodies to E. coli antigens and to MR1.
BL21-infected B-LCL were gated based on forward and side scatter
(FS/SS) and then through a “dump” channel used to eliminate dead
cells (ViViD+). B-LCL were then gated as E. coli− and E. coli+
respectively, and analyzed for their MR1 surface expression. (C) MR1
expression in the absence (none) or in the presence of inhibitors
lactacystin (LC) and cytochalasin D (CCD) at different concentrations.
B-LCLs were pretreated with LC and CCD for 2 h before infection. Data
are representative of five (A) and two (B,C) experiments.
over-expressing target system (40). Taken together, these results
demonstrated that bacterial infection might trigger MR1 to be
expressed at the cell surface using mainly endocytic pathway.
Moreover, this up-regulation might be a function of both, the
type target cell and the bacteria strain.
MAIT ARE ACTIVATED BY BACTERIA-INFECTED B CELLS
Despite of the reported B cell requirement for MAIT cell expan-
sion in the periphery (8), direct activation of MAIT cells by B cells
has not yet been reported (7). To directly evaluate this phenom-
enon, we investigated the role of cell-to-cell contact in MAIT cell
activation by performing experiments using transwell filters. In
these experiments MAIT cells were cultured in direct contact with
target cells (uninfected or BL21-infected B-LCLs) or separated by
transwell filters (0.4µm). Supernatants from infected-target cul-
tures that were cleared by centrifugation were used as controls for
microbial product effect. Human ex vivo PBMC were exposed for
16–18 h to B-LCL targets and activation and cytokine production
by MAIT cells were evaluated by flow cytometry. We selected 16–
18 h to minimize bystander stimulation while maintaining a close
parallel with the in vivo cytokine response (41). CD69, a very early
activation marker on lymphocytes, was used to monitor MAIT
cell activation (42). MAIT cells were identified as the double pos-
itive TCR Vα7.2+ CD161+ population. Under these experimental
conditions, MAIT cells in contact with infected B-LCLs, had an
increase in both the percentage of the early activation marker
CD69 and production of IL-17A IFN-γ and TNF-α cytokines
(Figure 4). In contrast, marginal or no increases were observed
in the percentage of activated or cytokines expressing MAIT cells
when cultured alone, in contact with uninfected B-LCLs, in the
presence of supernatant or separated from infected B-LCLs by
transwell filters. These results suggest that the increase in the
percentage of activated and cytokine-secreting MAIT cells was
dependent on cell-to-cell interactions (e.g., TCR engagement).
These results also demonstrated that soluble factors such microbial
products are not essential for MAIT cell activation in the absence
of target cells. To confirm the specificity of the MAIT cell activa-
tion, MAIT cells were exposed to Listeria-infected targets which
has previously been shown not to be activated by L. monocytogenes
(43). As expected MAIT cells only marginally responded to targets
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FIGURE 4 | Requirement of cell-to-cell contact for MAIT cells activation
by primary B cells. We investigated the role of cell-to-cell contact in the
MAIT cell activation by performing experiments using transwell filters. In
these experiments MAIT cells were cultured in direct contact with target cells
(uninfected or BL21-infected B-LCLs) or separated by transwell filters
(0.4µm). Supernatants from infected-target cell culture that were cleared by
centrifugation were used as control for microbial product effect. Human ex
vivo PBMC were exposed for 16–18 h to B-LCL targets and activation and
cytokine production by MAIT cells were evaluated by flow cytometry. Data
are representative of two experiments.
infected with Listeria as compared to E. coli strain BL21-infected
targets. These results further confirmed the specificity of MAIT
cell responses to members of the Enterobacteriaceae family, which
includes E. coli and Salmonella (Figure S4 in Supplementary Mate-
rial). Moreover, the frequency of IFN-γ+MAIT cells was markedly
reduced when infected-target cells were treated with mAbs to MR1
(clone 26.5) (Figure 5A). In these experiments, B-LCL cells were
infected with E. coli strain BL21, treated or not (none) with mAbs
to MR1 antigens (clone 26.5, 10µg/ml) or IgG2 isotype control
for 2 h and then exposed to MAIT cells. Because previous work has
shown the ability of fixed targets to activated MAIT cells (6, 7, 44),
we also compare frequency of IFN-γ+ MAIT cells exposed to live
infected targets or infected targets fixed in 1% paraformaldehyde.
Although infected targets fixed in 1% paraformaldehyde were able
to trigger an increase in the levels of IFN-γ+MAIT cells as com-
pared to controls (uninfected targets), levels of IFN-γ+MAIT cells
exposed to fixed targets were substantially lower than MAIT cells
exposed to live infected targets (Figure 5A). These results sup-
port the contention that bacteria-infected targets expressing MR1
on the cell surface are involved in MAIT cell activation. More-
over, based on the results of the experiments using fixed targets,
we could also propose that MR1 in a particular conformation
on the cell surface might be needed for an optimal MAIT cell
activation.
Although, B-LCL have intrinsic differences when compared
to primary B cells, it has been demonstrated that B cells dis-
play the same set of antigens observed in B cell lines (45). To
test this assumption, MAIT cells were exposed to primary B cells
isolated by negative selection from PBMC of healthy volunteers
and infected with E. coli strain BL21 at different MOI (1:0.3,
1:3, and 1:30) in the presence of mAbs to CD107 a and b. The
CD107 a and b antibodies were used to measure degranulation
(46). MAIT cells alone/or in the presence of uninfected targets
or phorbol myristate acetate (PMA, 50 ng/ml) plus ionomycin
(1µg/ml) were used as negative and positive controls respectively.
As shown in Figure 5B, MAIT cells were stimulated in a dose
dependent fashion by primary B cells infected with E. coli strain
BL21. MAIT cells were able to secrete IL-17A, IFN-γ, TNF-α, and
express CD107a/b. Taken together, these results are consistent with
the hypothesis that B cells are able to present antigens to MAIT
cells.
We next evaluated cytokine production by MAIT cells exposed
to B-LCL cells infected individually with each of the commensals
(i.e., E. coli strains BL21, Nissle 1917, or HS) or enteric pathogenic
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FIGURE 5 | Cytokine production by MAIT cells stimulated with
bacteria-infected-cells. (A) MAIT cells were exposed to either uninfected
(media) or BL21-infected B-LCL cells that were treated or not (none) with
monoclonal antibodies to MR1 antigens (clone 26.5), isotype control, or fixed
in 1% of paraformaldehyde (PFA). After 16–18 h co-culture, IFN-γ+ MAIT cell
was evaluated by flow cytometry. (B) Percentage of MAIT cells secreting
either IFN-γ, TNF-α, or IL-17A cytokines when exposed to primary B cells
infected with E. coli strain BL21 at different MOI (1:0.3, 1:3, and 1:30). Single
lymphocytes were gated based on forward scatter height vs. forward scatter
area. A “dump” channel was used to eliminate dead cells (ViViD+) as well as
macrophages/monocytes (CD14+), B lymphocytes (CD19+), and targets
(CD45+) from analysis. This was followed by additional gating on CD3, CD8,
TCRα7.2, and CD161 to identify CD107a/b+ and cytokine-producing (IFN-γ,
TNF-α, and IL-17A) MAIT cells. (C) Percentage of MAIT cells secreting either
IFN-γ, TNF-α, or IL-17A cytokines when exposed to commensal (i.e., E. coli
BL21, HS, or Nissle 1917 strains) or enteric pathogenic [S. typhi,
Enteropathogenic E. coli (EPEC), or Entero-Invasive E. coli (EIEC)]
bacteria-infected B-LCL cells were also evaluated. Bars represent mean±SE.
p Values of <0.05 were considered statistically significant. *Uninfected vs.
either commensal or pathogenic-infected targets. Comparisons between
groups were performed using Kruskal–Wallis One Way Analysis of Variance on
Ranks. Data are representative of two (A,B) and five (C) experiments.
(i.e., EPEC and EIEC) bacteria. We found that MAIT cells were
able to secrete IFN-γ, IL-17a, and TNF-α cytokines when exposed
to B-LCL cells infected with any of the commensal or enteric
pathogenic bacteria strains evaluated. Moreover, we observed that
the levels of cytokine production were indistinguishable between
MAIT cells stimulated by commensals or by pathogenic bacte-
ria. Aggregate data is shown in Figure 5C. Of note uninfected
B-LCLs triggered only limited cytokine production by MAIT cells
(Figure 5C). These results are in agreement with those obtained by
other groups using different MAIT cell stimulation systems show-
ing the ability of MAIT cells to secrete IFN-γ, IL-17a, and TNF-α
cytokines (9, 47). These results also support previous studies sug-
gesting that the MAIT TCR acts like a pattern recognition receptor,
with a conserved MR1-binding mode, irrespective of the source of
bacterial stimulation (48).
We next investigated to what extent the proportion of MAIT
cells secreting cytokines is influenced by the level of expres-
sion of MR1 or bacterial antigen expression on bacteria-infected
targets. Interestingly, although we found a correlation between
MR1 and bacterial antigen expression on bacteria-infected B-LCL
targets, there were no significant correlations between changes
in the expression of MR1 or bacterial antigen expression on
bacteria-infected targets and the proportion of MAIT cells secret-
ing cytokines (data not shown). As shown in Figure 6A; B-LCL
targets infected by different bacteria (i.e., S. typhi and E. coli
strains HS or EIEC) at the same MOI (1:30) induced different
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FIGURE 6 | Bacterial antigen expression and secretion of cytokines
by MAIT cells. B-LCL cells were left uninfected (none) or infected with
either Salmonella typhi or E. coli strains HS or EIEC. (A) Percentage of
B-LCL cells expressing bacterial antigens on their surface were
measured by flow cytometry. Targets infected with E. coli or S. typhi
were stained with antibodies to E. coli or CSA, respectively.
(B) Percentage of cytokine-secreting MAIT cells after 16–18 h of
co-culture with uninfected or infected-B-LCL targets. Cytokine
production by MAIT cells was evaluated by flow cytometry. Data are
representative of five experiments.
levels of infection on the target cells but similar levels of MAIT
cells secreting cytokines (Figure 6B). In addition, dose-response
studies showed that expression of bacterial antigens on the cell
surface depends on the MOI of bacteria being added. However, no
direct correlations were observed between the levels of expression
of bacteria on the cell surface of APC and MAIT cell activation
(Figure S5 in Supplementary Material). These results suggest that
MAIT cell responses might be independent of the levels of MR1 or
bacterial antigen expression on bacteria-infected targets, perhaps
after a certain expression threshold is achieved.
MAIT AND MULTI-FUNCTIONAL CYTOKINE PRODUCTION
Because our previous work supports the idea that multi-functional
T cells might contribute to effective Salmonella immunity (5, 49),
we then investigated the cytokine secretion patterns of MAIT
cells after exposure to infected B-LCL target cells. We measured
simultaneously three MAIT cell functions (IFN-γ, TNF-α, and IL-
17A cytokine secretion) by multichromatic flow cytometry using
the FCOM feature of WinList software which provides the % of
cells expressing each of the seven possible cytokine combinations.
Analyses of multiple cytokine patterns revealed that the majority
of MAIT cell responses were characterized by single or dou-
ble cytokine producers (Figure 7). Interestingly, at low bacterial
loads, IL-17A production in combination with other cytokines was
mostly linked to the presence of TNF-α. In most of the individuals
studied, at low bacterial loads of E. coli, MAIT cells that produce
concomitantly IFN-γ and IL-17A but not TNF-α were present a
very low frequency or absent but their frequency increased pro-
portionally to the bacterial load. We also observed that the levels
of MAIT cells that produce IL-17A were markedly lower in those
stimulated by B-LCL targets exposed to high bacteria loads than
those MAIT cells stimulated by B-LCL targets exposed to low bac-
teria loads. Surprisingly, no significant differences were observed
between cytokine patterns of MAIT cells stimulated by either com-
mensals or pathogens (Figures 7B–D). Furthermore, regardless
of the type of bacteria used to infect B-LCL cells, a statistically
significant difference was observed among triple vs. single and
double positive MAIT cells (Figures 7B–D). In fact the majority
of MAIT cells were single or double producers of cytokines. Inter-
estingly, the levels of MAIT cells that produce triple cytokines were
markedly higher in those stimulated by B-LCL targets exposed to
high bacteria loads than those of MAIT cells stimulated by B-LCL
targets exposed to low bacteria loads. Thus, it appears that the
quality of MAIT cell responses was dependent on bacterial load
rather than whether the bacteria is commensal or pathogenic.
Finally, we investigated the proportion of mono-functional and
multi-functional MAIT cells among CD8+ T cells. We found that
the proportion of MAIT cells among CD8+ T cells decreased as
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FIGURE 7 | Multi-functional response of MAIT cells against
commensal and pathogenic bacteria. (A) Immune responses of MAIT
cells against commensal E. coli strain Nissle (MOI 1:50 and 1:150) and
pathogenic Salmonella typhi (MOI 1:3 and 1:30) are shown. The response
patterns are color-coded by MAIT cells producing the indicated cytokines.
Numbers represent the percentages of MAIT cells secreting each cytokine
combination. (B–D) Pie charts show the proportion of MAIT cells
producing 1, 2, or 3 cytokines in response to stimulation with
bacteria-infected targets. Target cells were infected individually with
commensal (E. coli strains BL21, HS, or Nissle 1917) or pathogenic
bacteria (S. typhi, EPEC, or EIEC). Regardless of the type of stimulator
cells, statistical differences were found only between MAIT cells secreting
1 (single) or 2 (double) vs. 3 (triple) cytokines. *p Values of <0.05 were
considered statistically significant. No statistical differences were found
among the three pie charts: (B) MAITs exposed to any
bacteria-infected-cells (i.e., commensal or pathogenic), (C) MAITs exposed
to cells infected with commensal bacteria, and (D) MAITs exposed to cells
infected with pathogenic bacteria. Comparisons between groups were
performed using Kruskal–Wallis One Way Analysis of Variance on Ranks.
Data are representative of five experiments.
these CD8+ T cells became more multi-functional (Figure 8). We
also observed that the majority of mono-functional CD8+ T cells
were MAIT cells (Figure 8). These results reinforce the innate char-
acter of the MAIT cell immune responses bridging the adaptive T
cell immune responses.
DISCUSSION
These studies were directed to understand the origins of the back-
ground T cell immune responses observed before immunization in
individuals who are candidates to receive enteric bacterial vaccines
(1–5). A prevailing hypothesis is that these background responses
were due to the presence of cross-reactive T cells acquired during
previous infections by others enteric pathogens. A shortcoming of
this hypothesis is the fact that varying levels of these background
responses have been observed in most individuals regardless of a
history of previous or current enteric infections.
Recently it has been shown that uninfected individuals can har-
bor strong immune responses to Mtb as well as to enteric bacteria
such as E. coli and Salmonella (6) and that these responses are
mediated by MAIT cells. MAIT cells are a population of T cells
that display a TCR Vα7.2+ CD161+ phenotype and are restricted
by the non-classical MR1 molecule (7). Of note, MAIT cells are
abundant in the human intestine, and studies in mice suggest that
their accumulation in the periphery requires B cells and commen-
sal flora (7, 9). Therefore, we speculated that MAIT cell immune
responses directed not only to pathogens but also against com-
mensals might explain, at least in part, the background responses
observed before immunization.
In the present study we showed that bacterial infection of pri-
mary B cells and B cell lines with either commensals or enteric
pathogens from the Enterobacteriaceae family, triggers MAIT cell
activation followed by cytokine production. These results sup-
port the contention that B cells can function as APC to MAIT
cells. This is particularly important because although it has been
described that the accumulation of MAIT cells in the gut requires
MR1-expressing B cells (8), their role as APC remained unclear.
Interestingly, although we found a correlation between expression
of MR1 and bacterial antigens on bacteria-infected B cell targets,
there were no significant correlations among changes in the expres-
sion of MR1 or bacterial expression on bacteria-infected targets
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FIGURE 8 | Proportion of mono-functional and multi-functional MAIT
cells among CD8+ cells. FCOM, an analysis tool which automatically
reduces multiparameter data to a series of multiple event acquisition gates,
one for every possible sub-phenotype, was employed to study CD8+ cell
multifunctionality. Based on the defined positive staining regions, FCOM
calculated seven possible phenotypes, and displayed the event frequency
(%) for each of the seven sub-phenotypes in the separate gates shown in
the figure. Single lymphocytes were gated-out based on forward scatter
height vs. forward scatter area. A “dump” channel was used to eliminate
dead cells (ViViD+) as well as macrophages/monocytes (CD14+), B
lymphocytes (CD19+), and targets (CD45+) from analysis. This was followed
by additional gating on CD3 and CD8 to identify multi-functional CD8+ cells.
Subsequent gates on TCRα7.2 and CD161 were used to identify MAIT cells
among each of the seven defined sub-phenotypes of CD8+ cells. The data is
representative of one experiment showing mono-functional or
multi-functional MAIT cell responses to B-LCL cells infected with E. coli
strain HS at a multiplicity of infection (MOI) of 1:200. Data are representative
of five experiments.
and the proportion of MAIT cells producing cytokines. In fact,
very low levels of infection observed in targets infected with E. coli
strain HS induced similar levels of MAIT response as high level-
infected targets with S. typhi. These results appear to suggest that,
like other memory T cells (50), MAIT cells might need low levels of
antigenic stimulation to trigger their activation. Alternatively, or
concomitantly, we could hypothesize that reaching a specific bac-
terial antigen load threshold results in B-LCL targets expression of
appropriate levels of bacteria-induced B cell antigen(s) sufficient
to stimulate MAIT cells. Finally, we cannot discard the possibil-
ity that the levels of expression of the key bacterial antigens or
MR1 that trigger MAIT activation are not detected by the anti-
bodies used. Taken together, these results suggest that, the quality
of MAIT cell responses is more dependent on bacterial load than
on MR1 or expression of bacterial antigens on infected target cells.
Our observations that a specific bacterial load from different bac-
terial origins (e.g., E. coli strain Nissle or S. typhi) was able to
generate different levels of infection on the target cells but similar
levels of MAIT cells producing cytokines (Figure 5) supports this
theory.
Our results using infected targets fixed in 1% paraformaldehyde
showed that infected-fixed cells have a reduced ability to trigger
MAIT cell activation as compared to live targets. It is remark-
able that these results are similar to those reported by Le Bourhis
et al. (7) showing that fixed cells resulted in a marked decrease
(~70–80% reduction) in MAIT cell activation compared to live
cells using different experimental conditions. Le Bourhis et al. (7)
reported that MR1 molecules were induced to be overexpressed in
fibroblasts and bone marrow-derived dendritic cells prior to bac-
terial infection as opposed to the natural overexpression of MR1
after infection observed in primary B cells and B-LCL used in our
studies, as well as considerably higher MOI’s (up to 1,000:1) as
compared with our study (0.3–200). These results support the con-
tention that MR1 in a particular conformation on the cell surface
might be needed for optimal MAIT cell activation.
To our knowledge this is the first study uncovering evidence
indicating that bacterial load might play an important role in
the quality of MAIT cell responses. The specific mechanism(s) by
which the bacterial load exert(s) such a strong effect on the quality
of the MAIT cell responses remains to be determined. However, it
has been demonstrated that BCR-mediated endocytosis allows B
cells to concentrate more efficiently smaller than higher amounts
of proteins and BCR affinity can also affect the ensuing T cell
response qualitatively (28). In fact, Rivera and colleagues have
shown that B cells were required for systemic T cell priming when
the antigens were present in low amounts than when the antigens
were present at higher dose (51). By using transwell experiments in
which bacteria-infected B cells and effector cells are separated by
a physical barrier, we further confirmed that B cells can function
as APC for MAIT cell activation by showing the need of cell-to-
cell contact and the inability of soluble antigen alone, in absence
of target cells, to stimulate MAIT cells. Previous work has shown
that riboflavin metabolites, highly produced during bacteria over
growth, might serve as a ligand to MR1 and MAIT cells might
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use this riboflavin metabolites-MR1 immune complex to detect
microbial infection (52). The fact that the results of our transwell
filter experiments show that bacteria-infected targets and effec-
tor need to be in contact to trigger MAIT cell activation raises the
interesting possibility that, as with HLA class I, the loading of MR1
with such metabolites occurs might intracellularly. Further stud-
ies using an E. coli strain in which enzymes capable of B vitamin
metabolism have been genetically inactivated would contribute to
answer this important question.
In summary, here we demonstrated that bacterial infection
might provide a signal for endogenous MR1 proteins to be
expressed on the cell surface. Previous work has suggested this
as a possibility but direct evidence had not been provided. More-
over, we confirmed that B cells, both primary and B-LCL, function
as APCs for MAIT cells. Finally, we found that MAIT cells have a
diminished ability to secrete multiple cytokines than other CD8+
T cells. We believe that these novel and unique findings will con-
tribute to a better understanding of the role of MAIT cells on gut
immune surveillance.
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Figure S1 | Percentage of MR1-expressing MAIT cells after exposure to
uninfected or E. coli -infected B-LCLs. Three different MR1 antibodies were
tested: MR1 (clone 26.5) (kindly provided by Dr. Ted H. Hansen), MR1 (goat
polyclonal) [Santa Cruz Biotechnology (SC), San Diego, CA, USA], and MR1
(rabbit polyclonal) (GeneTex, Irvine, CA, USA). Data are representative of three
experiments.
Figure S2 | Binding of anti-E. coli antibodies to the different E. coli strains.
E. coli strains BL21, Nissle 1917, and HS were directly stained with six serial
twofold dilutions (from 3.8 to 120µg/ml) of anti-E. coli antibodies and analyzed
by flow cytometry. The results were then fitted in a four parameter logistic curve
using Prism software. Shown are median fluorescence intensity (MFI) of E.
coli -positive B-LCL cells.
Figure S3 | Capture but not only recognition is needed to up-regulate MR1.
B-LCL cells were cultured in medium alone or with lipid A (LPA) (1, 3, and
10µg/ml) for 2 h, washed, and incubated for an additional 16–18 h in complete
media. Cells were then Fc receptor-blocked with human IgG and stained with
rabbit anti-MR1 antibodies. After incubation cells were washed and incubated
with secondary donkey anti-rabbit-PE antibodies. Cells were then washed,
fixed, and analyzed by flow cytometry. (B) B-LCL cells untreated or treated with
CCD (2.5µg/ml) were infected with E. coli strain BL21 at a multiplicity of
infection (MOI) of 1:30 for 2 h and used as positive controls for the LPA
experiment (A). (C) Uninfected (medium) or E. coli -infected B-LCLs (E. coli )
were stained with normal rabbit serum, followed by secondary donkey
anti-rabbit-PE antibodies and used as control (background control). (D) E. coli
strain BL21 stained with rabbit anti-MR1 antibodies was used as an additional
control to assess cross-reactivity of the MR1 antibodies with E. coli ). Numbers
correspond to the % positive cells in the denoted quadrants. SSA, side scatter
area. Data are representative of one of two replicates with similar results.
Figure S4 | Listeria and MAIT cell activation. Target cells were left uninfected
(none) or infected with either Listeria monocytogenes (MOI 1:1, 1:10, and 1:50)
or E. coli strain BL21 (MOI 1:30). THP1, a human monocytic cell line, was used
as a target cells. Percentage of MAIT cells producing cytokines (IFN-γ and
TNF-α) or degranulating (CD107a/b) was detected after 16–18 h of co-culture
with uninfected or infected-B-LCL targets by flow cytometry. Data are
representative of two experiments.
Figure S5 | B cells activated MAIT cells in a dose dependent manner. B-LCL
cells were left uninfected (none) or infected with either Salmonella typhi (MOI
1:3 and 1:30) or E. coli strains HS (MOI 1:30 or 1:100). (A) Percentage of B-LCL
cells expressing bacterial antigens on their surface were measured by flow
cytometry. Targets infected with E. coli or S. typhi were stained with antibodies
to E. coli or CSA, respectively. (B) Percentage of cytokine-secreting MAIT cells
after 16–18 h of co-culture with uninfected or infected-B-LCL targets. Cytokine
production by MAIT cells was evaluated by flow cytometry. Data are
representative of five experiments.
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